Bayesian Capital Management’s CNA Financial CNA Stock Holding History

Bayesian Capital Management’s Portfolio CNA Stock Details CNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,968	Closed	-$227K	–	645
2018 Q2	$227K	Sell	4,968 -2,974	-37%	-$144K	0.05%	487
2018 Q1	$392K	Buy	+7,942	New	+$415K	0.1%	328

Other funds holding CNA

Loews Corp New York $11.9B AUM 8.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bayesian Capital Management's CNA Position: Q3 2018 in Review

Bayesian Capital Management sold out of CNA Financial (CNA) in Q3 2018, closing a stake of 4,968 shares — an estimated $227K sold.

Bayesian Capital Management first reported a position in CNA in Q1 2018 and held it in 2 quarters. The position peaked at $392K in Q1 2018. 193 funds tracked by Wall St. Rank hold CNA as of Q3 2018.

Bayesian Capital Management reported no remaining CNA Financial position as of Q3 2018 after selling out during the quarter.
Bayesian Capital Management sold 4,968 CNA Financial shares in Q3 2018, an estimated $227K.
Bayesian Capital Management first reported a position in CNA Financial in Q1 2018 and held it in 2 quarters.
Bayesian Capital Management's CNA Financial position peaked at $392K in Q1 2018.
193 funds tracked by Wall St. Rank held CNA Financial as of Q3 2018.

Based on Bayesian Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.